Results 151 to 160 of about 31,215 (290)

Haemoglobin A1c Time‐In‐Range and Mortality in Adults With Diabetes

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Reduced A1c time in range and particularly greater time below range are associated with increased mortality in adults with diabetes. A1c stability within person‐specific ranges may be a risk predictor for major outcomes in adults with diabetes. ABSTRACT Introduction Glycemic variability over time is a risk factor for diabetes complications.
Paul R. Conlin, Julia C. Prentice, David C. Mohr, Libin Zhang, Donglin Li, Erin Pleasants, Richard E. Nelson, Suma Vupputuri, Gregory A. Nichols   +8 more
wiley   +1 more source

Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation. [PDF]

BMJ Med
Xie Y, Choi T, Al-Aly Z.
europepmc   +1 more source

The Effect of Integrated Lifestyle Intervention Incorporating Calorie‐Carbohydrate Restriction With or Without Time‐Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Diabetes remission is possible through weight loss. Behavioural lifestyle program is effective to achieve diabetes remission. ABSTRACT Aims We conducted the diet and diabetes remission (DIREM) study to assess whether an integrated lifestyle intervention would lead to achieving remission in type 2 diabetes.
Negin Badrooj, Alireza Esteghamati, Kurosh Djafarian, Mir Saeed Yekaninejad, Saba Mohammadpour, Vida Dankoob, Sahar Karimpour Reyhan, Mahsa Abbaszade, Sara Emamgholipour, Sakineh Shab‐Bidar   +9 more
wiley   +1 more source

Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study. [PDF]

Ann Med
Gao M, Lin Q, Hu K, Zhong B, Zhu T, Gong Z, Zhang K, Chen X, Chen X, Zhang Y, Li Y, Tang S, Su D, Liang X, Liu Y.   +14 more
europepmc   +1 more source

A Multicentre, Prospective, Non‐Interventional Single‐Arm Study Investigating the Impact of Once‐Daily Oral Semaglutide in a Real‐World Adult Population With Type 2 Diabetes in Mexico

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Initiation of oral semaglutide in patients with T2D in routine clinical practice in Mexico significantly reduces HbA1c and weight and improves satisfaction with treatment. ABSTRACT Background To investigate the oral semaglutide use among Mexican adults with type 2 diabetes.
Guillermo González‐Gálvez, Juan C. Garnica‐Cuellar, Miguel Ángel Colín‐García, Aldo Ferreira‐Hermosillo, Silvia A. Jiménez‐Ramos, Aleida Y. Contreras‐Sandoval, Patricia Cruz‐Puente, Manuel Duarte‐Vega   +7 more
wiley   +1 more source

Hepatogenous diabetes in the era of precision medicine: diagnosis, management, and future directions. [PDF]

Clin Exp Med
El-Azab G, Rady MA, Assem M, Nagdy H.
europepmc   +1 more source

Depression following the initiation of glucagon‐like‐peptide‐1 receptor agonist therapy: A multinational self‐controlled case series study

Journal of Internal Medicine, Volume 299, Issue 6, Page 776-780, June 2026.
Vincent Ka Chun Yan, Zi‐Yang Peng, Vincent Kai Chung Wong, Ian Chi Kei Wong, Esther Wai Yin Chan, Huang‐Tz Ou, Eric Yuk Fai Wan   +6 more
wiley   +1 more source

Hypolipidemic and Hypoglycemic Activity of Goat Milk–Derived Peptides

Food Frontiers, Volume 7, Issue 3, May 2026.
Goat milk–derived bioactive peptides IASAEPTVH, LSTSEENSKK, and TEDELQDK exerted favorable hypolipidemic and hypoglycemic properties. ABSTRACT The prevalence of diabetes and hyperlipidemia worldwide has increased in recent decades. This study aimed to investigate the potential hypoglycemic and hypolipidemic effects of bioactive peptides derived from ...
Rui Wang, Yun Yang, Xinhua Ouyang, Rong He, Xingyun Wang, Xiaoqing Chen   +5 more
wiley   +1 more source

Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]

BMJ Open Diabetes Res Care
Sklepinski S, Ratzki-Leewing AA, Herrin J, Swarna KS, Deng Y, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG.   +15 more
europepmc   +1 more source

Pharmacological Evaluation of Methanolic Fruit Extract of Lannea coromandelica: Antioxidant, Cytotoxic, Antidiabetic, Antibacterial, Anti‐Inflammatory, and Sedative Activities

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Phytochemical investigation of Lannea coromandelica through GC–MS and in silico analysis revealed diverse bioactive compounds with promising pharmacological potential. Integrated in vitro and in vivo assays demonstrated significant antioxidant, antidiabetic, antibacterial, anti‐inflammatory, and sedative activities, supporting its therapeutic relevance.
Priota Islam Meem, Zobayed Islam, Nazmul Hasan Eshaque, Md. Jahirul Islam Mamun, Khurram Murad Mojidee, Mohammad Badrudduja, Amit Kumar Dam, S. M. Moazzem Hossen   +7 more
wiley   +1 more source